Australia's PYC Therapeutics surges on eye-treatment drugs progress

PYC Therapeutics

03/04/2023 02:02

** Shares of Australia's PYC Therapeutics Ltd  PYC.AX  climb
as much as 9.2% to A$0.071 - set to rise the most since March 9,
if current gains hold
    ** Biotech co expects to have two first-in-class and
potentially disease-modifying drugs addressing different
blinding eye diseases in human trials by mid-2024
    ** Stock hits highest level since March 28
    ** Stock down 5.8% this year, as of last close

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))